Mo Chen

Dr. Mo Chen

Menzies Health Institute Queensland, Griffith University, University Drive, Southport, QLD 4222, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
RRRonak Reshamwala
Ronak Reshamwala
MMMariyam Murtaza
Mariyam Murtaza
MCMo Chen
Mo Chen
MSMegha Shah
Megha Shah
JEJenny Ekberg
Jenny Ekberg
James St JohnJames St John
James St John
Spinal cord injury (SCI) represents an urgent unmet need for clinical reparative therapy due to its largely irreversible and devastating effects on patients, and the tremendous socioeconomic burden to the community. While different approaches are being explored, therapy to restore the lost function remains unavailable. Olfactory ensheathing cell (OEC) transplantation is a promising approach in terms of feasibility, safety, and limited efficacy; however, high variability in reported clinical outcomes prevent its translation despite several clinical trials. The aims of this position paper are to present an in-depth analysis of previous OEC transplantation-based clinical trials, identify existing challenges and gaps, and finally propose strategies to improve standardization of OEC therapies. We have reviewed the study design and protocols of clinical trials using OEC transplantation for SCI repair to investigate how and why the outcomes show variability. With this knowledge and our experience as a team of biologists and clinicians with active experience in the field of OEC research, we provide recommendations regarding cell source, cell purity and characterisation, transplantation dosage and format, and rehabilitation. Ultimately, this position paper is intended to serve as a roadmap to design an effective clinical trial with OEC transplantation-based therapy for SCI repair.

1 July 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YTYu-Ting Tseng
Yu-Ting Tseng
RLRichard Lai
Richard Lai
FOFrancesca Oieni
Francesca Oieni
ASAndrea Standke
Andrea Standke
GSGraham Smyth
Graham Smyth
JEJenny Ekberg
Jenny Ekberg
Cell transplantation using olfactory ensheathing cells (OECs) is a promising approach for nerve repair but there are numerous limitations with their delivery method. Three-dimensional (3D) cell culture systems potentially offer a powerful approach for cell production and delivery options. To further optimise the use of OECs, strategies to promote cell viability and maintain cell behaviours in 3D cultures become important. We previously demonstrated an anti-diabetic drug, liraglutide, could modulate OEC migration and re-model extracellular matrix in two-dimensional (2D) cultures. In the present study, we further investigated its beneficial effects in our 3D culture system using primary OECs. OECs treated with liraglutide at 100 nM showed improved cell viability and had modulated expression of N-cadherin and β1-integrin (two important cell adhesion molecules). When formed into 3D spheroids, the pre-treated OECs generated spheroids with an increased volume and a decreased cell density compared to control spheroids. OECs that subsequently migrated out of the liraglutide pre-treated spheroids had higher capacity for migration with increased duration and length, which was attributed to a reduction in the pauses during the migration. Moreover, OECs that migrated out from liraglutide spheroids had a more bipolar morphology consistent with higher migratory capacity. In summary, liraglutide improved the viability of OECs, modulated cell adhesion molecules, and resulted in stable 3D cell constructs which conferred enhanced migratory capacity on the OECs. Overall, liraglutide may potentially improve the therapeutic use of OECs for neural repair by enhancing the generation of stable 3D constructs and increasing the migratory behaviour of OECs.

7 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
XCXiaoyi Chen
Xiaoyi Chen
RFRocio Finol-Urdaneta
Rocio Finol-Urdaneta
MCMo Chen
Mo Chen
ASAlex Sykes
Alex Sykes
BGBingmiao Gao
Bingmiao Gao
ASAlex Skye
Alex Skye
Parkinson’s disease (PD) is a complex, progressive neurodegenerative disorder driven by multiple pathogenetic factors, including oxidative stress, mitochondria dysfunction, neuroinflammation, and ion imbalance. Recent evidence highlights the significant role of potassium channels in the pathophysiology of PD. We recently identified a PD-linked genetic mutation in the KCNJ15 gene ( KCNJ15 p.R28C ), encoding the inwardly rectifying potassium channel Kir4.2, within a four-generation family with familial PD. However, the role of the Kir4.2 channel in neurodegenerative diseases remains largely unexplored. This study aimed to elucidate the impact of the KCNJ15 p.R28C (Kir4.2 R28C ) mutation on the biophysical and biochemical properties of Kir4.2. Employing Kir4.2-overexpressing HEK293T cells as a model, we investigated how the mutation affects the channel’s functional properties, total protein expression, intracellular processing in the endoplasmic reticulum and lysosomes, and plasma membrane trafficking. Patch clamp studies revealed that the Kir4.2 R28C mutation results in loss of channel function with significant dominant-negative effects. This dysfunction is partially attributed to the substantial reduction in overall mutant channel protein expression compared to the wild-type (Kir4.2 WT ). We observed that both Kir4.2 WT and Kir4.2 R28C proteins undergo glycosylation during the post-translational modification process, albeit with differing protein turnover efficiencies. Furthermore, the Kir4.2 R28C mutant exhibits reduced stability and compromised plasma membrane trafficking capacity compared to Kir4.2 WT . These findings suggest that the Kir4.2 R28C mutant has unique biomolecular and biophysical characteristics distinct from the Kir4.2 WT channel, which potentially elucidates its role in the pathogenesis of PD. Key Points: ➢ Inwardly rectifying potassium channels are increasingly recognized for their critical role in the complex pathogenesis of Parkinson’s disease (PD) ➢ We previously identified a genetic mutation, Kir4.2 R28C , in the inwardly rectifying potassium channel Kir4.2, which strongly segregates with familial PD in a multi- generational pedigree. ➢ This study confirms Kir4.2 R28C as a loss-of-function mutation with significant dominant- negative effects, impairing channel activity even in heterozygous conditions. ➢ The Kir4.2 R28C mutation significantly reduces overall protein levels, impairs protein stability and disrupts plasma membrane trafficking in in vitro cell models.
1